<unk>  (trade names Prolia and Xgeva) is a human monoclonal antibody for the treatment of osteoporosis, treatment-induced bone loss, metastases to bone, and giant cell tumor of bone.<unk>  is contraindicated in people with low blood calcium levels. The most common side effects are joint and muscle pain in the arms or legs.<unk>  is a inhibitor of RANKL (receptor activator of nuclear factor kappa-Β ligand), which works by preventing the development of osteoclasts, which are cells that break down bone. It was developed by the biotechnology company Amgen.
Denosumab
Medronic acid
Zoledronic acid
Alendronic acid
Risedronic acid
Teriparatide
Pamidronic acid
Ibandronic acid